PUBLISHER: TechNavio | PRODUCT CODE: 2172409
PUBLISHER: TechNavio | PRODUCT CODE: 2172409
Global Cancer Registry Software Market 2026-2030
The global cancer registry software market is forecasted to grow by USD 122078.1 thousand during 2025-2030, accelerating at a CAGR of 12.8% during the forecast period. The report on the global cancer registry software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer prevalence and requirement for evidence-based public health policy, integration of AI and machine learning for enhanced data abstraction and accuracy, evolution of precision medicine and demand for granular genomic data integration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.9% |
| CAGR | 12.8% |
| Incremental Value | $122078.1 thousand |
Technavio's global cancer registry software market is segmented as below:
By End-User
- Government and third party
- PBM companies
- Hospitals and medical practice
- Private payers
- Research institutes
By Type
- Stand-alone software
- Integrated software
By Deployment
- On-premises
- Cloud-based
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the universal transition toward cloud-native architectures and SAAS delivery models as one of the prime reasons driving the global cancer registry software market growth during the next few years. Also, proliferation of real-world evidence and multi-source data fusion for comprehensive clinical insights and advancement in automated data abstraction and implementation of semantic interoperability standards will lead to sizable demand in the market.
The report on the global cancer registry software market covers the following areas:
- Global cancer registry software market sizing
- Global cancer registry software market forecast
- Global cancer registry software market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cancer registry software market vendors that include Azra AI Inc., Conduent Inc., CureMD, Dacima Software Inc., Elekta AB, Epic Systems Corp., Flatiron Health, Health Catalyst Inc., ImageTrend Inc., Inspirata Inc., IQVIA Holdings Inc., McKesson Corp., Merative L.P., NeuralFrame Inc., Oracle Corp., Ordinal Data Inc., RaySearch Laboratories, Siemens Healthineers AG, Skill Information S Co. Ltd., Veradigm LLC. Also, the global cancer registry software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cancer Registry Software Market 2020 - 2024
- Historic Market Size - Data Table on Global Cancer Registry Software Market 2020 - 2024 ($ thousand)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.4 Deployment segment analysis 2020 - 2024
- Historic Market Size - Deployment Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Cancer Registry Software Market
- 6.2 Impact of Geopolitical Conflicts on Global Cancer Registry Software Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Government and third party - Market size and forecast 2025-2030
- 8.4 PBM companies - Market size and forecast 2025-2030
- 8.5 Hospitals and medical practice - Market size and forecast 2025-2030
- 8.6 Private payers - Market size and forecast 2025-2030
- 8.7 Research institutes - Market size and forecast 2025-2030
- 8.8 Market opportunity by End-user
- Market opportunity by End-user ($ thousand)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Stand-alone software - Market size and forecast 2025-2030
- 9.4 Integrated software - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
10 Market Segmentation by Deployment
- 10.1 Market segments
- 10.2 Comparison by Deployment
- 10.3 On-premises - Market size and forecast 2025-2030
- 10.4 Cloud-based - Market size and forecast 2025-2030
- 10.5 Market opportunity by Deployment
- Market opportunity by Deployment ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising cancer prevalence and requirement for evidence-based public health policy
- Integration of AI and machine learning for enhanced data abstraction and accuracy
- Evolution of precision medicine and demand for granular genomic data integration
- 13.2 Market challenges
- Data interoperability and international standardisation hurdles
- Data privacy regulations and cybersecurity vulnerabilities
- High implementation costs and integration complexity
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Universal transition toward cloud-native architectures and SaaS delivery models
- Proliferation of real-world evidence and multi-source data fusion for comprehensive clinical insights
- Advancement in automated data abstraction and implementation of semantic interoperability standards
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Conduent Inc.
- Conduent Inc. - Overview
- Conduent Inc. - Business segments
- Conduent Inc. - Key offerings
- Conduent Inc. - Segment focus
- SWOT
- 15.5 CureMD
- CureMD - Overview
- CureMD - Product / Service
- CureMD - Key offerings
- SWOT
- 15.6 Elekta AB
- Elekta AB - Overview
- Elekta AB - Business segments
- Elekta AB - Key offerings
- Elekta AB - Segment focus
- SWOT
- 15.7 Epic Systems Corp.
- Epic Systems Corp. - Overview
- Epic Systems Corp. - Product / Service
- Epic Systems Corp. - Key offerings
- SWOT
- 15.8 Flatiron Health
- Flatiron Health - Overview
- Flatiron Health - Product / Service
- Flatiron Health - Key offerings
- SWOT
- 15.9 Health Catalyst Inc.
- Health Catalyst Inc. - Overview
- Health Catalyst Inc. - Business segments
- Health Catalyst Inc. - Key offerings
- Health Catalyst Inc. - Segment focus
- SWOT
- 15.10 ImageTrend Inc.
- ImageTrend Inc. - Overview
- ImageTrend Inc. - Product / Service
- ImageTrend Inc. - Key offerings
- SWOT
- 15.11 Inspirata Inc.
- Inspirata Inc. - Overview
- Inspirata Inc. - Product / Service
- Inspirata Inc. - Key offerings
- SWOT
- 15.12 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 15.13 McKesson Corp.
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
- SWOT
- 15.14 Merative L.P.
- Merative L.P. - Overview
- Merative L.P. - Product / Service
- Merative L.P. - Key offerings
- SWOT
- 15.15 Oracle Corp.
- Oracle Corp. - Overview
- Oracle Corp. - Business segments
- Oracle Corp. - Key news
- Oracle Corp. - Key offerings
- Oracle Corp. - Segment focus
- SWOT
- 15.16 RaySearch Laboratories
- RaySearch Laboratories - Overview
- RaySearch Laboratories - Product / Service
- RaySearch Laboratories - Key offerings
- SWOT
- 15.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.18 Veradigm LLC
- Veradigm LLC - Overview
- Veradigm LLC - Product / Service
- Veradigm LLC - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
